CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- 4/A Grant or award Chief Financial Officer acquired 3,482 shares (grant or award)
- 4/A Grant or award Chief Operating Officer acquired 3,726 shares (grant or award)
- 4 Grant or award VP Finance and Treasurer acquired 1,503 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 3,334 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 3,522 shares (grant or award)
- 4 Grant or award Director acquired 2,716 shares (grant or award)
- 4 Grant or award See Remarks acquired 2,478 shares (grant or award)
- 4 Grant or award Executive Chairman acquired 12,103 shares (grant or award)
- 4 Grant or award See Remarks acquired 1,547 shares (grant or award)
- 4 Grant or award President and CEO acquired 11,699 shares (grant or award)
- 4 Other disposition Executive Chairman disposed of 2,303 shares (other)
- 4 Other disposition See Remarks disposed of 265 shares (other)
- 4 Other disposition Chief Operating Officer disposed of 635 shares (other)
- 4 Other disposition See Remarks disposed of 472 shares (other)
- 4 Other disposition Chief Financial Officer disposed of 840 shares (other)
- 4 Other disposition President and CEO disposed of 486 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $31.77 ($317,700)
- 4 Planned sale President and CEO sold 18,608 shares at an average $54.61 ($1,016,228)
- 4 Planned sale President and CEO sold 21,120 shares at an average $53.86 ($1,137,593)
Page 1 of 17 · 334 filings